Mouwasat Medical Services Company (TADAWUL:4002)

Market Cap	11.03B -25.2%
Revenue (ttm)	3.37B +11.4%
Net Income	850.41M +20.5%
EPS	4.25 +20.5%
Shares Out	200.00M
PE Ratio	12.97
Forward PE	12.46
Dividend	2.13 (3.85%)
Ex-Dividend Date	Oct 18, 2026

Volume	202,132
Open	54.80
Previous Close	54.60
Day's Range	54.80 - 55.95
52-Week Range	52.45 - 74.25
Beta	0.11
Analysts	Buy
Price Target	79.40 (+43.97%)
Est. Earnings	Mar 4, 2027

About TADAWUL:4002

Mouwasat Medical Services Company, together with its subsidiaries, engages in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, and pharmacies in the Kingdom of Saudi Arabia. The company operates a network of hospitals that provides medical services and specialized centers, including eye, obesity, cardiology, diabetic, robotic, fertility, rehabilitation, long term care, stroke, and skincare center. It also provides various services comprising inpatient pharmacy services, TPN and IV medication pr...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1974
• Employees: 2,389
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4002

Financial Performance

In 2025, TADAWUL:4002's revenue was 3.22 billion, an increase of 11.92% compared to the previous year's 2.88 billion. Earnings were 822.04 million, an increase of 27.30%.

Analyst Summary

According to 13 analysts, the average rating for 4002 stock is "Buy." The 12-month stock price target is SAR 79.40, which is an increase of 43.97% from the latest price.

Price Target

SAR 79.40

(43.97% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 6, 2026

Data Sources Report a data error